SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
17597552
Source:
http://linkedlifedata.com/resource/pubmed/id/17597552
Search
Subject
(
57
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0008425
,
umls-concept:C0008976
,
umls-concept:C0087111
,
umls-concept:C0560005
,
umls-concept:C1554080
,
umls-concept:C1706198
pubmed:issue
1
pubmed:dateCreated
2007-12-12
pubmed:abstractText
This paper reviews the key lessons learned from the first published short-term, placebo-controlled trial of a cholinesterase inhibitor for treatment of mild cognitive impairment (MCI).
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9007918
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Cholinesterase Inhibitors
,
http://linkedlifedata.com/resource/pubmed/chemical/Indans
,
http://linkedlifedata.com/resource/pubmed/chemical/Piperidines
,
http://linkedlifedata.com/resource/pubmed/chemical/Placebos
,
http://linkedlifedata.com/resource/pubmed/chemical/donepezil
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1041-6102
pubmed:author
pubmed-author:CorreiaStephenS
,
pubmed-author:RichardsonSharonS
,
pubmed-author:SallowayStephenS
pubmed:issnType
Print
pubmed:volume
20
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
40-6
pubmed:meshHeading
pubmed-meshheading:17597552-Aged
,
pubmed-meshheading:17597552-Alzheimer Disease
,
pubmed-meshheading:17597552-Cholinesterase Inhibitors
,
pubmed-meshheading:17597552-Cognition Disorders
,
pubmed-meshheading:17597552-Cohort Studies
,
pubmed-meshheading:17597552-History, 20th Century
,
pubmed-meshheading:17597552-Humans
,
pubmed-meshheading:17597552-Indans
,
pubmed-meshheading:17597552-Memory Disorders
,
pubmed-meshheading:17597552-Neuropsychological Tests
,
pubmed-meshheading:17597552-Outcome Assessment (Health Care)
,
pubmed-meshheading:17597552-Piperidines
,
pubmed-meshheading:17597552-Placebos
,
pubmed-meshheading:17597552-Psychiatric Status Rating Scales
,
pubmed-meshheading:17597552-Psychomotor Performance
,
pubmed-meshheading:17597552-Randomized Controlled Trials as Topic
,
pubmed-meshheading:17597552-Research Design
,
pubmed-meshheading:17597552-Severity of Illness Index
,
pubmed-meshheading:17597552-Treatment Outcome
,
pubmed-meshheading:17597552-United States
pubmed:year
2008
pubmed:articleTitle
Key lessons learned from short-term treatment trials of cholinesterase inhibitors for amnestic MCI.
pubmed:affiliation
Department of Clinical Neurosciences Brown Medical School, Rhode Island, USA. SSalloway@butler.org
pubmed:publicationType
Journal Article
,
Comparative Study
,
Randomized Controlled Trial
,
Historical Article
,
Multicenter Study